Research in developmental disabilities
Mar 15, 2025
This study explored differences in the attributional patterns of four advanced artificial intelligence (AI) Large Language Models (LLMs): ChatGPT3.5, ChatGPT4, Claude, and Gemini) by focusing on feedback, frustration, sympathy, and expectations of fu...
Clinical trials are pivotal in drug development yet fraught with uncertainties and resource-intensive demands. The application of AI models to forecast trial outcomes could mitigate failures and expedite the drug discovery process. This review discus...
Pflugers Archiv : European journal of physiology
Mar 15, 2025
The rapid integration of artificial intelligence (AI) into surgical practice necessitates a comprehensive evaluation of its applications, challenges, and physiological impact. This systematic review synthesizes current AI applications in surgery, wit...
BACKGROUND: Artificial intelligence (AI) has shown immense potential in the field of medicine, but its actual effectiveness and safety still need to be validated through clinical trials. Currently, the research themes, methodologies, and development ...
Artificial intelligence (AI) holds great promise for analyzing complex data to advance patient care and disease research. For example, AI interpretation of retinal imaging may enable the development of noninvasive retinal biomarkers of systemic disea...
OBJECTIVES: To develop and validate an explainable Artificial Intelligence (AI) model for classifying and quantifying upper airway obstruction related to adenoid hypertrophy using three-dimensional (3D) shape analysis of cone-beam computed tomography...
Pulse oximetry, although generally effective under ideal conditions, faces challenges in accurately estimating peripheral oxygen saturation (SpO) in complex clinical scenarios, particularly at lower saturation levels and in patients with darker skin ...
Unhealthy lifestyle behaviors are a doorway to downstream health consequences characterized by the following: 1) poor quality of life and diminished mobility; 2) increased likelihood of chronic disease risk factors and diagnoses; and, ultimately, 3) ...
The deployment of artificial intelligence (AI) is revolutionizing neuropharmacology and drug development, allowing the modulation of neurotransmitter systems at the personal level. This review focuses on the neuropharmacology and regulation of neurot...
Join thousands of healthcare professionals staying informed about the latest AI breakthroughs in medicine. Get curated insights delivered to your inbox.